Clinical Trials Logo
  1. Home
  2. Adrenoleukodystrophy
  3. NCT00278044
  4. Details
NCT00278044 Clinical Trial

Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children

Adrenoleukodystrophy Clinical Trial

Official title:
Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT00278044
Other study ID # 94028
Secondary ID
Status Recruiting
Phase N/A
First received January 16, 2006
Last updated February 6, 2009
Start date January 2006
Est. completion date July 2007

Study information
Verified date January 2006
Source Far Eastern Memorial Hospital
Contact jao shwann liang, MD
Phone 02-89667000
Email j580414@yahoo.com.tw
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Interventional

Clinical Trial Summary

Study the clinical manifestations and gene mutation of Taiwanese ALD patients

Recruitment information / eligibility
Status Recruiting
Enrollment 20
Est. completion date July 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- X-ALD patients and family

Exclusion Criteria:

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Intervention

Procedure:
• blood sampling and medical records

Locations
Country Name City State
Taiwan Far Eastern Memorial Hospital Taipei

Sponsors (3)
Lead Sponsor Collaborator
Far Eastern Memorial Hospital Fu Jen Catholic University, National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

See also
  Status Clinical Trial Phase
Recruiting NCT02254863 - UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells Phase 1
Completed NCT00383448 - HSCT for High Risk Inherited Inborn Errors Phase 2
Recruiting NCT05687474 - Baby Detect : Genomic Newborn Screening
Completed NCT02961803 - MD1003-AMN MD1003 in Adrenomyeloneuropathy Phase 2/Phase 3
Withdrawn NCT02948062 - Early Diagnosis Of Childhood Cerebral ALD
Completed NCT02952482 - Newborn Screening for Adrenoleukodystrophy
Recruiting NCT03789721 - Adrenoleukodystrophy National Registry Study
Completed NCT04303416 - Plasma Exchange With Albumin in AMN Patients Phase 2/Phase 3
Terminated NCT00545597 - A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy Phase 3
Completed NCT03513328 - Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation Phase 1/Phase 2
Active, not recruiting NCT02699190 - LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Recruiting NCT02559830 - Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy Phase 1/Phase 2
Completed NCT00176904 - Stem Cell Transplant for Inborn Errors of Metabolism Phase 2/Phase 3
Completed NCT00007020 - Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid Phase 3
Active, not recruiting NCT03231878 - A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients. Phase 2/Phase 3
Recruiting NCT03047369 - The Myelin Disorders Biorepository Project
Recruiting NCT04925349 - Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
Active, not recruiting NCT00005900 - Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation N/A
Completed NCT00004450 - Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy N/A
Recruiting NCT04090268 - Precision Exercise in Children With Malignant Hemopathies N/A